Getein Biotech (SHSE:603387) 3-Year Revenue Growth Rate : 6.80% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Getein Biotech 3-Year Revenue Growth Rate?

Getein Biotech's Revenue per Share for the three months ended in Mar. 2024 was ¥0.64.

During the past 12 months, Getein Biotech's average Revenue per Share Growth Rate was -20.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 6.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 17.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 12 years, the highest 3-Year average Revenue per Share Growth Rate of Getein Biotech was 26.80% per year. The lowest was 6.80% per year. And the median was 24.80% per year.

Competitive Comparison of Getein Biotech's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Getein Biotech's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Getein Biotech's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Getein Biotech's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Getein Biotech's 3-Year Revenue Growth Rate falls into.

Getein Biotech 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Getein Biotech (SHSE:603387) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Getein Biotech 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Getein Biotech's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Getein Biotech (SHSE:603387) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getein Biotech Inc (SHSE:603387) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 9 Bofu Road, Luhe District, Nanjing, CHN, 211505

Website

http://www.bio-gp.com.cn

Getein Biotech Inc is an in-vitro diagnostic company. It is specializing in analytical medical devices and point-of-care testing kits. Its product lines consist of cardiovascular, inflammatory, diabetes, fertility, renal, liver and specialty assays.

Executives

Su En Kui	Director
Yan Bin	Director
Kong Ting Ting	Director
Xu Xing De	Director
Su En Ben	Director

Getein Biotech (SHSE:603387) Headlines

No Headlines